Clinical Trial Update: A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating abemaciclib in combination with radiation therapy for metastatic breast cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Breast Cancer, Stage IV Breast Cancer | Phase 1 | Status: RECRUITING